Literature DB >> 12407423

Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway.

E Neumann1, M Judex, F Kullmann, J Grifka, P D Robbins, T Pap, R E Gay, C H Evans, S Gay, J Schölmerich, U Müller-Ladner.   

Abstract

The objective of the study was to determine the effects and the molecular background of interleukin-1 receptor antagonist (IL-1Ra) and vIL-10 double gene transfer into human synovial fibroblasts from patients with rheumatoid arthritis (RA) using the SCID mouse model for cartilage erosion in RA. RA synovial fibroblasts were transduced with retro- or adenoviruses encoding IL-1Ra and/or viral IL-10 (vIL-10). SCID mice were engrafted subcutaneously with IL-1Ra and vIL-10 transduced human rheumatoid synovial fibroblasts and normal cartilage. In parallel, gene expression analysis before and after gene transfer using RNA arbitrarily primed PCR in combination with cDNA array was performed. vIL-10 and IL-1Ra double gene transfer resulted in inhibition of cartilage invasion and degradation by RA synovial fibroblasts when compared with control transduced and non-transduced implants. Expression of key genes that were altered after double gene transfer were related to the activin pathway. The results demonstrate not only that virus-based gene transfer using a combination of two joint-protective genes is a feasible approach to inhibit cartilage degradation by activated RA synovial fibroblasts, but also that the underlying molecular effects include modulation of the activin pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407423     DOI: 10.1038/sj.gt.3301811

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  16 in total

1.  A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration.

Authors:  Christine L Le Maitre; Anthony J Freemont; Judith A Hoyland
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

2.  Interleukin-17 (IL-17) and IL-1 activate translation of overlapping sets of mRNAs, including that of the negative regulator of inflammation, MCPIP1.

Authors:  Sonam Dhamija; Reinhard Winzen; Anneke Doerrie; Gesine Behrens; Nancy Kuehne; Celina Schauerte; Elena Neumann; Oliver Dittrich-Breiholz; Michael Kracht; Helmut Holtmann
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

3.  Activin A suppresses interleukin-1-induced matrix metalloproteinase 3 secretion in human chondrosarcoma cells.

Authors:  Deh-Ming Chang; Shao-Hsiang Liu; Herng-Sheng Lee; Jenn-Hung Lai; Chen-Hung Chen
Journal:  Rheumatol Int       Date:  2007-04-14       Impact factor: 2.631

4.  Visfatin/pre-B-cell colony-enhancing factor (PBEF), a proinflammatory and cell motility-changing factor in rheumatoid arthritis.

Authors:  Florian M P Meier; Klaus W Frommer; Marvin A Peters; Fabia Brentano; Stephanie Lefèvre; Dirk Schröder; Diego Kyburz; Jürgen Steinmeyer; Stefan Rehart; Steffen Gay; Ulf Müller-Ladner; Elena Neumann
Journal:  J Biol Chem       Date:  2012-07-05       Impact factor: 5.157

Review 5.  Gene therapy approaches to regenerating the musculoskeletal system.

Authors:  Christopher H Evans; Johnny Huard
Journal:  Nat Rev Rheumatol       Date:  2015-03-17       Impact factor: 20.543

6.  Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts.

Authors:  Elena Neumann; Birgit Riepl; Anette Knedla; Stephanie Lefèvre; Ingo H Tarner; Joachim Grifka; Jurgen Steinmeyer; Jurgen Schölmerich; Steffen Gay; Ulf Müller-Ladner
Journal:  Arthritis Res Ther       Date:  2010-05-12       Impact factor: 5.156

Review 7.  Gene Delivery to Joints by Intra-Articular Injection.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Hum Gene Ther       Date:  2018-01       Impact factor: 5.695

8.  Synovial fibroblasts spread rheumatoid arthritis to unaffected joints.

Authors:  Stephanie Lefèvre; Anette Knedla; Christoph Tennie; Andreas Kampmann; Christina Wunrau; Robert Dinser; Adelheid Korb; Eva-Maria Schnäker; Ingo H Tarner; Paul D Robbins; Christopher H Evans; Henning Stürz; Jürgen Steinmeyer; Steffen Gay; Jürgen Schölmerich; Thomas Pap; Ulf Müller-Ladner; Elena Neumann
Journal:  Nat Med       Date:  2009-11-08       Impact factor: 53.440

Review 9.  Concepts in gene therapy for cartilage repair.

Authors:  Andre F Steinert; Ulrich Nöth; Rocky S Tuan
Journal:  Injury       Date:  2008-04       Impact factor: 2.586

10.  Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells.

Authors:  Frank Tacke; Erwin Gäbele; Frauke Bataille; Robert F Schwabe; Claus Hellerbrand; Frank Klebl; Rainer H Straub; Tom Luedde; Michael P Manns; Christian Trautwein; David A Brenner; Jürgen Schölmerich; Bernd Schnabl
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.